TOP > 外国特許検索 > PEPTIDE FRAGMENT FOR TREATING AUTOIMMUNE DISEASES

PEPTIDE FRAGMENT FOR TREATING AUTOIMMUNE DISEASES 新技術説明会

外国特許コード F170009151
整理番号 S2015-1886-C0
掲載日 2017年8月16日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2016JP071224
国際公開番号 WO 2017018288
国際出願日 平成28年7月20日(2016.7.20)
国際公開日 平成29年2月2日(2017.2.2)
優先権データ
  • 特願2015-150344 (2015.7.30) JP
発明の名称 (英語) PEPTIDE FRAGMENT FOR TREATING AUTOIMMUNE DISEASES 新技術説明会
発明の概要(英語) Provided is a new means for effectively treating diseases including autoimmune diseases and the like. This peptide fragment has an amino acid sequence from position 46 to position 73, an amino acid sequence from position 160 to position 181, or an amino acid sequence from position 235 to position 261 in the amino acid sequence of carbonic anhydrase I (CAI), and includes 35 amino acid residues or less.
特許請求の範囲(英語) [claim1]
1. Amino acid arrangement of 46th rank - 73rd rank of carbonic acid dehydrogenase I (CAI) amino acid arrangement, amino acid arrangement of 160th rank - 181st rank, or amino acid arrangement of 235th rank - 261st rank is included, the peptide fragment which consists of the amino acid arrangement which is 35 amino acid residues or less.
[claim2]
2. It includes the amino acid arrangement of 46th rank - 73rd rank of carbonic acid dehydrogenase I (CAI) amino acid arrangement, it consists of the amino acid arrangement which is 35 amino acid residues or less, in claim 1 peptide fragment of statement.
[claim3]
3. Remedy or prevention of the autoimmune disease which contains the peptide fragment of statement in claim 1 or 2 the medicine composition
[claim4]
4. It is for oral administration, in claim 3 the medicine composition of statement.
[claim5]
5. In claim 1 or 2 in peptide fragment of statement unique magnanimous field characteristic antigen presentation cell.
[claim6]
6. It is the controllable tree-like cell, in claim 5 the magnanimous field characteristic antigen presentation cell of statement.
[claim7]
7. In claim remedy or prevention of the autoimmune disease which includes the magnanimous field characteristic antigen presentation cell of statement 5 or 6 the medicine composition.
[claim8]
8. In claim 1 or 2 the polynucleotide which peptide fragment of statement the cord/code is done.
[claim9]
9. The vector which includes the polynucleotide of statement in claim 8.
[claim10]
10. The transformant which installs the vector of statement in claim 9.
[claim11]
11. Remedy or prevention of the autoimmune disease which includes the transformant of statement in claim 10 the medicine composition.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • EHIME UNIVERSITY
  • 発明者(英語)
  • HIASA YOICHI
  • YAGI SEN
  • ABE MASANORI
  • IKEDA YOSHIOH
  • YAMASHITA MASAKATSU
国際特許分類(IPC)
指定国 (WO201718288)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KN KP KR KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
四国TLOは四国内20大学・高専のシーズをご紹介しております。シーズの詳細内容につきましては下記までお問い合わせください。
お問い合わせをお待ちしております。

PAGE TOP

close
close
close
close
close
close